Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Hamidi

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
JAMA Oncology|July 11, 2024
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus StatementSarah Hamidi, Ramona Dadu, Mark E Zafereo, et al.
JCO Precision Oncology|February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2026
Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic <i>BRAF</i> Wild-Type Anaplastic Thyroid CarcinomaSarah Hamidi, Danica M Vodopivec, Naifa L Busaidy, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenuesSarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
PRECISE: A prognostic thyrocyte-derived gene signature for papillary thyroid carcinomaSophie Li, Chia-Chin Wu, Vicente R Marczyk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2024
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy DeferralStephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
JAMA Oncology|July 11, 2024
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus StatementSarah Hamidi, Ramona Dadu, Mark E Zafereo, et al.
JCO Precision Oncology|February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2026
Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic <i>BRAF</i> Wild-Type Anaplastic Thyroid CarcinomaSarah Hamidi, Danica M Vodopivec, Naifa L Busaidy, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenuesSarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
PRECISE: A prognostic thyrocyte-derived gene signature for papillary thyroid carcinomaSophie Li, Chia-Chin Wu, Vicente R Marczyk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2024
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy DeferralStephanie O Dudzinski, Maria E Cabanillas, Sarah Hamidi, et al.
Pageof 3